US Patent 10179820 Anti-HER2 antibodies and immunoconjugates
Patent 10179820 was granted and assigned to Genentech on January, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+110 characters)
Article
Patent abstract
The invention provides anti-HER2 antibodies and immunoconjugates and methods of using the same.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Gail Lewis Phillips0
Jagath Reddy Junutula0
Mark Dennis0
Mark X. Sliwkowski0
Thomas Harden Pillow0
Xiaocheng Chen0
Edits on 2 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101798200
Date of Patent
January 15, 2019
0Patent Application Number
152964540
Date Filed
October 18, 2016
0Patent Citations Received
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 2 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 24 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10179820 Anti-HER2 antibodies and immunoconjugates
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10179820
Date of patent
January 15, 2019
Patent application number
15296454
Date Filed
October 18, 2016
Patent primary examiner
Find more entities like US Patent 10179820 Anti-HER2 antibodies and immunoconjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.